[1]李晓勤,王 群,何晓兰,等.多模式镇痛对原发性肝癌患者休斯顿疼痛情况调查表评分及血清结合珠蛋白水平的影响[J].陕西医学杂志,2024,(4):475-478.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.008]
　LI Xiaoqin,WANG Qun,HE Xiaolan,et al.InfLuences of multimodal analgesia on HPOI score and serum haptoglobin level in patients with hepatocellular carcinoma[J].,2024,(4):475-478.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.008]
点击复制

多模式镇痛对原发性肝癌患者休斯顿疼痛情况调查表评分及血清结合珠蛋白水平的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年4期
页码:
475-478
栏目:
临床研究
出版日期:
2024-04-05

文章信息/Info

Title:
InfLuences of multimodal analgesia on HPOI score and serum haptoglobin level in patients with hepatocellular carcinoma
作者:
李晓勤; 王 群; 何晓兰; 吕 岩; 王锦龙
(空军军医大学第一附属医院麻醉与围术期医学科,陕西 西安 710032)
Author(s):
LI Xiaoqin; WANG Qun; HE Xiaolan; LYU Yan; WANG Jinlong
(Department of Anesthesia and Perioperative Medicine,the First Affiliated Hospital of Air Force Medical University,Xi'an 710032,China)
关键词:
原发性肝癌;  多模式镇痛;  HPOI评分;  疼痛;  血清结合珠蛋白;  不良反应
Keywords:
Hepatocellular carcinoma;  Multimodal analgesia;  HPOI score;  Pain;  Serum bound globin;  Adverse reactions
分类号:
R 735.7
DOI:
DOI:10.3969/j.issn.1000-7377.2024.04.008
文献标志码:
A
摘要:
目的:探究多模式镇痛(MA)对原发性肝癌(HCC)患者休斯顿疼痛情况调查表(HPOI)评分及血清结合珠蛋白水平的影响。方法:选择原发性肝癌患者78例作为研究对象,按照随机数字表法分组,分为对照组(n=39,给予传统镇痛方式)与观察组(n=39,在对照组的基础上采取多模式镇痛方式)。比较两组患者的HPOI评分、不良反应情况,并测定两组患者血清结合珠蛋白水平。结果:干预后,观察组镇痛药使用少于对照组(P<0.05)。观察组HPOI评分优于对照组(P<0.05)。观察组术后8、12、24 h VAS评分均低于对照组(均P<0.05)。干预后,两组患者血清结合珠蛋白水平均有所降低(P<0.05),且观察组血清结合珠蛋白水平低于对照组(P<0.05)。观察组恶心呕吐、胃肠道不适、呼吸抑制、头晕头痛等不良反应率较对照组低(均P<0.05)。结论:多模式镇痛能够有效提升原发性肝癌患者镇痛满意度,减少术后镇痛药物使用,缓解病情。
Abstract:
Objective:To explore the influences of multimodal analgesia(MA)on the Houston Pain Outcome Instrument(HPOI)score and serum haptoglobin level in patients with hepatocellular carcinoma(HCG).Methods:Seventy-eight patients with primary liver cancer were regarded as the research subjects,and grouped into control group(39 cases,given traditional analgesia)and observation group(39 cases,given multimodal analgesia on the basis of control group)according to random number table method.The total HPOI score,and adverse reactions were compared between the two groups,and the serum haptoglobin levels were determined in the two groups.Results:After the intervention,the use of analgesics in the observation group was less than that in the control group(P<0.05).The HPOI score of the observation group was better than that of the control group(P<0.05).The VAS scores of the observation group at 8,12 and 24 hours after operation were lower than those of the control group(all P<0.05).After the intervention,the serum haptoglobin levels of the two groups were decreased,and the serum haptoglobin level in the observation group was lower than that in the control group(all P<0.05).The ADR rate of nausea,vomiting,gastrointestinal discomfort,respiratory depression,dizziness and headache in the observation group was lower than that in the control group(P<0.05).Conclusion:Multimodal analgesia can effectively improve the analgesic satisfaction of patients with primary liver cancer,reduce postoperative analgesics use,and relieve the disease,which is worthy of application and promotion.

参考文献/References:

[1] 钟瑜,包仕廷.代谢类新药诊治和预防原发性肝癌的研究进展[J].广东医科大学学报,2022,40(2):238-241.
[2] 庾麒,李琴,蒋凯,等.原发性肝癌的发病机制和BUB1表达的临床意义[J].临床肿瘤学杂志,2020,25(4):39-44.
[3] 刘贤国,徐红玉,朱江.原发性肝癌伴门静脉癌栓产生机制及经导管肝动脉化疗栓塞术联合其他介入方案治疗研究进展[J].陕西医学杂志,2023,52(10):1438-1441.
[4] 雷妙,陈海丽,鹿婷婷,等.中药汤剂联合坎地沙坦治疗晚期原发性肝癌临床疗效[J].辽宁中医杂志,2022,49(3):143-146.
[5] 高丽华.探讨在肝癌开腹术后患者疼痛控制中采用多模式镇痛护理干预的影响[J].中国医药指南,2021,19(21):142-143.
[6] 刘立友,吴东洋,蔡青山,等.原发性肝癌组织中层粘连蛋白3、黏着斑激酶蛋白表达及其与患者临床病理特征和预后关系研究[J].陕西医学杂志,2023,52(9):1259-1263.
[7] 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版)[J].中华肝脏病杂志,2017,25(12):886-895.
[8] 郭祥冲,谢杰,许镇.羟考酮复合右美托咪定对胃癌根治术患者术后镇痛的效果[J].医学临床研究,2018,35(2):350-351.
[9] HARTKE J,JOHNSON M,GHABRIL M.The diagnosis and treatment of hepatocellular carcinoma[J].Semin Diagn Pathol,2017,34(2):153-159.
[10] ALAWYIA B,CONSTANTINOU C.Hepatocellular carcinoma:A narrative review on current knowledge and future prospects[J].Curr Treat Options Oncol,2023,24(7):711-724.
[11] 龙林,孙林,刘觉仕,等.探究介入治疗中晚期原发性肝癌患者的临床疗效及对肝功能的影响[J].当代医学,2022,28(12):9-12.
[12] 倪逸斐,薛茵,陈琳.多模式镇痛护理对肝癌开腹术后患者疼痛控制情况的研究[J].中国肿瘤临床与康复,2022,29(4):488-490.
[13] 田俊波.帕瑞昔布钠超前镇痛联合右美托咪定复合局部麻醉在经皮椎间孔镜手术中的应用效果[J].临床合理用药杂志,2022,15(15):130-132.
[14] WEN N,CAI Y,LI F,et al.The clinical management of hepatocellular carcinoma worldwide:A concise review and comparison of current guidelines:2022 Update[J].Biosci Trends,2022,16(1):20-30.
[15] YOON S M,RYOO B Y,LEE S J,et al.Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion:A randomized clinical trial[J].JAMA Oncol,2018,4(5):661-669.
[16] 闫芍药,聂会勇,王锁良.加味双柏散外敷联合耳穴压豆对肝癌介入治疗患者疼痛评分及生活质量影响[J].陕西中医,2020,41(12):1763-1766.
[17] 乔喜婷,王昊,杨林,等.复元活血汤合化积丸联合肝动脉栓塞化疗术治疗原发性肝癌临床研究[J].陕西中医,2019,40(8):998-1000.
[18] 赵蜀川,徐广民,李明芳.区域神经阻滞在肝脏切除术后镇痛的研究进展[J].实用医院临床杂志,2023,20(3):184-187.
[19] 倪逸斐,薛茵,陈琳.多模式镇痛护理对肝癌开腹术后患者疼痛控制情况的研究[J].中国肿瘤临床与康复,2022,29(4):488-490.
[20] 柯琦,罗鸿萍,李蓉蓉,等.多模式镇痛在肝癌肝部分切除术病人中的应用[J].护理研究,2019,33(20):3611-3612.
[21] 郭芳,王江华,饶慧瑛,等.阿德福韦酯治疗慢性乙型肝炎患者前后蛋白质组学的比较分析[J].中华检验医学杂志,2007,30(1):48-52.
[22] 杨鑫,刘小静,张曦,等.血清触珠蛋白、降钙素原、白介素-6联合检测对肝硬化合并自发性细菌性腹膜炎的诊断及其预后分析[J].实用医院临床杂志,2020,17(5):144-147.
[23] 邓婕,邓敏.触珠蛋白和铁蛋白在结肠癌肝转移患者预后评估中的意义[J].检验医学,2022,37(12):1151-1156.
[24] 杨海娇,杨广民.结合珠蛋白基因多态性与HBV相关性肝细胞癌易感性的关系分析[J].吉林医学,2020,41(2):276-277.
[25] 李秀荣,孙雪,任怡然,等.人血清结合珠蛋白的生物信息学分析[J].中国医学装备,2019,16(10):89-93.

相似文献/References:

[1]郭俊霞,魏晓华.乙肝肝硬化患者合并原发性肝癌的危险因素及预后分析*[J].陕西医学杂志,2019,(7):850.
[2]李 珣,张祥林.肝动脉化疗栓塞联合恩替卡韦对原发性肝癌治疗效果及对患者血清中恶性肿瘤特异性生长因子的影响[J].陕西医学杂志,2019,(7):873.
　LI Xun,ZHANG Xianglin..Efficacy observation and TSGF change in primary hepatocellular carcinoma by TACE and entecavir[J].,2019,(4):873.
[3]陶 琳.原发性肝癌患者化疗后抗菌药物的应用及继发感染的危险因素分析[J].陕西医学杂志,2023,52(1):89.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.021]
　TAO Lin.Application of antibiotics and risk factors of secondary infection in patients with primary liver cancer after chemotherapy[J].,2023,52(4):89.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.021]
[4]刘立友,吴东洋,蔡青山,等.原发性肝癌组织中层粘连蛋白3、黏着斑激酶蛋白表达及其与患者临床病理特征和预后关系研究[J].陕西医学杂志,2023,52(9):1259.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.034]
　LIU Liyou,WU Dongyang,CAI Qingshan,et al.Expression of LAMA3 and FAK proteins in primary liver cancer and their relationship with clinicopathological features and prognosis of patients[J].,2023,52(4):1259.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.034]
[5]刘贤国,徐红玉,朱 江.原发性肝癌伴门静脉癌栓产生机制及经导管肝动脉化疗栓塞术联合其他介入方案治疗研究进展[J].陕西医学杂志,2023,52(10):1438.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.036]
　LIU Xianguo,XU Hongyu,ZHU Jiang.Research progress on mechanism of thrombus formation of primary liver cancer with portal vein cancer and application progress of TACE combined with other interventional protocols[J].,2023,52(4):1438.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.036]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(81971058)
更新日期/Last Update: 2024-04-07